Cite
HARVARD Citation
Chaplin, S. et al. (n.d.). Dapagliflozin: first SGLT2 inhibitor for type 2 diabetes. Prescriber. 24 (12), pp. 13-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chaplin, S. et al. (n.d.). Dapagliflozin: first SGLT2 inhibitor for type 2 diabetes. Prescriber. 24 (12), pp. 13-16. [Online].